Natera (NTRA) Reports Q4 Earnings: What Key Metrics Have to Say

Group 1 - Natera reported revenue of $476.06 million for the quarter ended December 2024, reflecting a 53% increase year-over-year [1] - The company's EPS was -$ 0.41, an improvement from - $0.64 in the same quarter last year [1] - Revenue exceeded the Zacks Consensus Estimate of$ 471.92 million by 0.88%, and EPS also surpassed the consensus estimate of - $0.42 by 2.38% [1] Group 2 - The volume of tests processed was 792,800, exceeding the average estimate of 771,561 based on three analysts [4] - Licensing and other revenues were reported at$ 3.15 million, below the four-analyst average estimate of $3.48 million, representing a year-over-year decline of 18.3% [4] - Product revenues reached$ 472.90 million, significantly higher than the average estimate of $406.47 million, marking a year-over-year increase of 53.9% [4] Group 3 - Natera's stock has returned -19.2% over the past month, compared to a -5.6% change in the Zacks S&P 500 composite [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating potential performance in line with the broader market in the near term [3]